Anti-Caspase-5 antibody [EP876Y]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(11 Publications)
Rabbit Recombinant Monoclonal Caspase-5 antibody. Suitable for IHC-P, IP, WB and reacts with Human samples. Cited in 11 publications.
View Alternative Names
ICH3, CASP5, Caspase-5, CASP-5, ICE(rel)-III, Protease ICH-3, Protease TY
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Caspase-5 antibody [EP876Y] (AB40887)
Stainign of Caspase 5 on paraffin-embedded human breast carcinoma sections using ab40557 at a 1/50 dilution. Heat mediated antigen retrieval was performed with citrate buffer pH 6 before commencing with IHC staining protocol.
- IP
Lab
Immunoprecipitation - Anti-Caspase-5 antibody [EP876Y] (AB40887)
Purified ab40887 at 1/50 dilution (2μg) immunoprecipitating Caspase-5 in HeLa treated with heat shock (42°C 1h) then recovery for 6h whole cell lysate.
Blocking and diluting Buffer and concentration : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-Caspase-5 antibody [EP876Y] (ab40887)
Lane 1:
HeLa (Human cervix adenocarcinoma epithelial cell) treated with heat shock (42°C 1h) then recovery for 6h whole cell lysate (Input) at 10 µg
Lane 2:
ab40887 + HeLa treated with heat shock (42°C, 1h) then recovery for 6h whole cell lysate
Lane 3:
<a href='/en-us/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a> instead of ab40887 in HeLa treated with heat shock (42°C 1h) then recovery for 6h whole cell lysate (-)
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/1000 dilution
Predicted band size: 50 kDa
Observed band size: 47 kDa
false
- WB
Unknown
Western blot - Anti-Caspase-5 antibody [EP876Y] (AB40887)
The cell lysates were prepared in 1%SDS Hot lysis method.
All lanes:
Western blot - Anti-Caspase-5 antibody [EP876Y] (ab40887) at 1/10000 dilution
All lanes:
HeLa cell lysate at 10 µg
Predicted band size: 50 kDa
Observed band size: 47 kDa
false
- WB
Lab
Western blot - Anti-Caspase-5 antibody [EP876Y] (AB40887)
Blocking/Diluting Buffer and concentration :
5% NFDM/TBST
All lanes:
Western blot - Anti-Caspase-5 antibody [EP876Y] (ab40887) at 1/1000 dilution
All lanes:
HT-1080 (Human fibrosarcoma epithelial cell) prepared in 1%SDS Hot lysis method whole cell lysates at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 50 kDa
Observed band size: 47 kDa
false
- WB
CiteAb
Western blot - Anti-Caspase-5 antibody [EP876Y] (AB40887)
Caspase-5 western blot using anti-Caspase-5 antibody [EP876Y] ab40887. Publication image and figure legend from Zhang, Z., Shao, X., et al., 2018, Cell Death Dis, PubMed 30250284.
ab40887 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab40887 please see the product overview.
Iohexol induces TEC pyroptosis via activation of inflammatory caspases in mice and humans.a ELISA detection of mature IL-1β in human TEC culture supernatants 72 h after TECs treated with iohexol in a dose-dependent manner. b Immunoblot analysis of the inflammatory caspase-11 in mouse TECs and the inflammatory caspases 4/5 in human TECs with extracellular iohexol (20 mg/ml) or isosmotic mannitol for 72 h. c Quantification of the inflammatory caspases expression shows significant upregulation of caspase-11 and caspases 4/5 in mouse and human TECs, respectively. Statistics obtained from ANOVA. d mRNA expression of inflammatory caspases was determined by real-time PCR in human TECs after a 72 h period of iohexol (20 mg/ml) or isosmotic mannitol incubation. e Release of LDH showed that iohexol (20 mg/ml) or isosmotic mannitol incubation for 16 h led to marked cell lysis. Cell lysis was blocked by the pan-caspase inhibitor Z-VAD-FMK. f Incubation with iohexol (20 mg/ml) or isosmotic mannitol for 72 h increased mature IL-1β secretion, measured by ELISA in cell culture supernatants, whereas the response was abrogated by the pan-caspase inhibitor Z-VAD-FMK. Experiments were performed in triplicate. Ctrl, control. **p < 0.01, ***p < 0.001 vs. control or as indicated. Data are means ± SEM. Statistics obtained from ANOVA
false
Related conjugates and formulations (1)
-
Anti-Caspase-5 antibody [EP876Y] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (11)
Recent publications for all applications. Explore the full list and refine your search
Journal of dental sciences 20:1422-1435 PubMed40654428
2025
Applications
Unspecified application
Species
Unspecified reactive species
Communications biology 8:737 PubMed40355718
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 14:29769 PubMed39616227
2024
Applications
Unspecified application
Species
Unspecified reactive species
Aging 15:8113-8136 PubMed37595258
2023
Applications
Unspecified application
Species
Unspecified reactive species
Biomolecules 12: PubMed36359010
2022
Applications
Unspecified application
Species
Unspecified reactive species
Evidence-based complementary and alternative medicine : eCAM 2021:4836992 PubMed34853599
2021
Applications
Unspecified application
Species
Unspecified reactive species
The EMBO journal 40:e108080 PubMed34747049
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 9:983 PubMed30250284
2018
Applications
Unspecified application
Species
Unspecified reactive species
The veterinary quarterly 34:137-42 PubMed24865775
2014
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 5:e16012 PubMed21209843
2010
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com